Literature DB >> 8956029

X-linked juvenile retinoschisis: localization between (DXS1195, DXS418) and AFM291wf5 on a single YAC.

H Pawar1, E L Bingham, K Hiriyanna, M Segal, J E Richards, P A Sieving.   

Abstract

We studied 17 pedigrees with 108 affected males with X-linked juvenile retinoschisis (RS; McKusick No. 31270) and have analyzed all of the known polymorphic markers in the RS region of Xp22.1-p22.2 between DXS987 and DXS41. By haplotype analyses we found 7 individuals who showed crossovers in this interval surrounding RS. We previously reported AFM291wf5 as the centromeric boundary, and this remains unchanged in the present study. A new recombination was identified on the telomeric side at (DXS1195, DXS418). Our data support the locus order Xpter--(DXS987, DXS207, DXS1053, DXS43)--(DXS1195, DXS418)--(RS, DXS257, DXS999)--(AFM291wf5, DXS443)--DXS1052--(DXS1226, DXS274, DXS41)--Xcen; loci grouped in parentheses could not be mutually ordered by our genetic data. Physical mapping has indicated a distance of at most 900-1,000 kb between (DXS1195, DXS418) and AFM291wf5. No recombination was observed between RS and DXS257 which lies in our new interval of interest, but one critical individual was not informative with this marker. Our data now define the smallest RS inclusion interval. This interval is contained on a single YAC from which we have identified expressed sequences as candidate genes for RS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956029     DOI: 10.1159/000154373

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  2 in total

1.  Juvenile retinoschisis: a model for molecular diagnostic testing of X-linked ophthalmic disease.

Authors:  P A Sieving; B M Yashar; R Ayyagari
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  Visual impairment in the absence of dystroglycan.

Authors:  Jakob S Satz; Alisdair R Philp; Huy Nguyen; Hajime Kusano; Jane Lee; Rolf Turk; Megan J Riker; Jasmine Hernández; Robert M Weiss; Michael G Anderson; Robert F Mullins; Steven A Moore; Edwin M Stone; Kevin P Campbell
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.